| Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study JG Mattia, MJ Vandy, JC Chang, DE Platt, K Dierberg, DG Bausch, ... The Lancet Infectious Diseases 16 (3), 331-338, 2016 | 192 | 2016 |
| The breadth of viruses in human semen AP Salam, PW Horby Emerging infectious diseases 23 (11), 1922, 2017 | 187 | 2017 |
| Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection Y Wang, G Fan, A Salam, P Horby, FG Hayden, C Chen, J Pan, J Zheng, ... The Journal of infectious diseases 221 (10), 1688-1698, 2020 | 162 | 2020 |
| Terrestrial stress analogs for spaceflight associated immune system dysregulation B Crucian, RJ Simpson, S Mehta, R Stowe, A Chouker, SA Hwang, ... Brain, behavior, and immunity 39, 23-32, 2014 | 117 | 2014 |
| Chronic artificial blue-enriched white light is an effective countermeasure to delayed circadian phase and neurobehavioral decrements RP Najjar, L Wolf, J Taillard, LJM Schlangen, A Salam, C Cajochen, ... PloS one 9 (7), e102827, 2014 | 107 | 2014 |
| Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study DL Fink, H Callaby, A Luintel, W Beynon, H Bond, EY Lim, ... The Lancet Infectious Diseases 23 (5), 589-597, 2023 | 63 | 2023 |
| Immune sensitization during 1 year in the Antarctic high‐altitude Concordia Environment M Feuerecker, BE Crucian, R Quintens, JI Buchheim, AP Salam, A Rybka, ... Allergy 74 (1), 64-77, 2019 | 50 | 2019 |
| Early adaption to the antarctic environment at dome C: consequences on stress-sensitive innate immune functions M Feuerecker, B Crucian, AP Salam, A Rybka, I Kaufmann, M Moreels, ... High altitude medicine & biology 15 (3), 341-348, 2014 | 44 | 2014 |
| Prognostic factors for T1–T2 squamous cell carcinomas of the mobile tongue: a retrospective cohort study L Bonnardot, E Bardet, O Steichen, E Cassagnau, B Piot, AP Salam, ... Head & neck 33 (7), 928-934, 2011 | 44 | 2011 |
| Time to reconsider the role of ribavirin in Lassa fever AP Salam, V Cheng, T Edwards, P Olliaro, J Sterne, P Horby PLoS neglected tropical diseases 15 (7), e0009522, 2021 | 43 | 2021 |
| Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study A Duvignaud, M Jaspard, IC Etafo, D Gabillard, B Serra, C Abejegah, ... The Lancet Global Health 9 (4), e469-e478, 2021 | 43 | 2021 |
| Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza Y Wang, W Zhong, A Salam, J Tarning, Q Zhan, J Huang, H Weng, C Bai, ... EBioMedicine 62, 2020 | 41 | 2020 |
| A low-cost tele-imaging platform for developing countries K Adambounou, V Adjenou, AP Salam, F Farin, KG N’Dakena, ... Frontiers in public health 2, 135, 2014 | 40 | 2014 |
| Melioidosis acquired by traveler to Nigeria AP Salam, N Khan, H Malnick, DTD Kenna, DAB Dance, JL Klein Emerging infectious diseases 17 (7), 1296, 2011 | 39 | 2011 |
| Trained innate immunity: a salient factor in the pathogenesis of neuroimmune psychiatric disorders AP Salam, A Borsini, PA Zunszain Molecular Psychiatry 23 (2), 170-176, 2018 | 35 | 2018 |
| Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing AP Salam, A Duvignaud, M Jaspard, D Malvy, M Carroll, J Tarning, ... PLoS Neglected Tropical Diseases 16 (3), e0010289, 2022 | 34 | 2022 |
| A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections L Sigfrid, C Perfect, A Rojek, KS Longuere, S Lipworth, E Harriss, J Lee, ... BMC medicine 17, 1-17, 2019 | 33 | 2019 |
| Complications of miliary tuberculosis: low mortality and predictive biomarkers from a UK cohort J Underwood, F Cresswell, AP Salam, AJ Keeley, C Cleland, L John, ... BMC infectious diseases 17, 1-7, 2017 | 30 | 2017 |
| A corticoid-sensitive cytokine release assay for monitoring stress-mediated immune modulation M Feuerecker, W Mayer, I Kaufmann, M Gruber, F Muckenthaler, B Yi, ... Clinical & Experimental Immunology 172 (2), 290-299, 2013 | 29 | 2013 |
| Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design L Merson, J Bourner, S Jalloh, A Erber, AP Salam, A Flahault, PL Olliaro PLOS Neglected Tropical Diseases 15 (9), e0009788, 2021 | 26 | 2021 |
